RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
6.45
+0.07 (1.10%)
Sep 8, 2026, 4:00 PM EDT - Market closed
RxSight Market Cap
RxSight has a market cap or net worth of $268.28 million as of September 8, 2026. Its market cap has decreased by -26.25% in one year.
Market Cap
268.28M
Enterprise Value
70.06M
1-Year Change
-26.25%
Ranking
Category
Stock Price
$6.45
ChartMarket Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $268.28M, a decrease of -36.78%. That is a compound annual growth rate of -8.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 268.28M | -37.38% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Perspective Therapeutics | 357.29M |
| AVITA Medical | 346.38M |
| Viemed Healthcare | 345.84M |
| Treace Medical Concepts | 312.82M |
| TriSalus Life Sciences | 307.87M |
| CapsoVision | 299.78M |
| Standard BioTools | 269.11M |
| Profound Medical | 251.91M |